Concepedia

Yezhe Cheng

YC

Statistics

Publications

4

Citations

198

H-Index

4

Active since

2017

Affiliations

Kelun Group (China)(Current)

Kanion Pharmaceutical (China)

Shenyang Pharmaceutical University

Yezhe Cheng is an author at Kelun Group (China) specializing in pharmacology, pharmacodynamics of anticancer drugs, and menorrhagia treatment.

Publications per year

2017–2022

4

Publications

4

Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132

Yezhe Cheng, Xiaoxi Yuan, Qiang Tian et al. · Frontiers in Oncology · 2022 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetic–pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats

Yezhe Cheng, Yanjie Chu, Xitong Su et al. · Phytomedicine · 2018 · 60 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Systematic screening and characterization of multiple constituents in Guizhi Fuling capsule and metabolic profiling of bioactive components in rats using ultra-high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry

Yu Zhang, Yezhe Cheng, Zhongbo Liu et al. · Journal of Chromatography B · 2017 · 35 citations

Life Sciences, Biochemistry, Pharmacology +17

Randomized, double-blinded, placebo-controlled phase I study of the pharmacokinetics, pharmacodynamics, and safety of KL130008, a novel oral JAK inhibitor, in healthy subjects

Na Li, Shuangqing Du, Ying Wang et al. · European Journal of Pharmaceutical Sciences · 2022 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

1–4 of 4